Background: Parkinson’s disease (PD) is the second most common neurodegenerative disorder, characterized by progressive loss of dopaminergic neurons, leading to both motor and non-motor symptoms. Although dopaminergic therapy is the current goldstandard therapy in symptomatic management, it does not alter disease progression. Meditation, a complementary therapy, has shown promise in alleviating...
Background: Meditation, rooted in ancient traditions, has gained prominence as a tool for managing stress in modern health and wellness. This study aims on the impact of long-term Vipassana meditation on the regulation of stress hormones, including cortisol, adrenaline, growth hormone, and glucagon, to explore its physiological benefits.Methods: This comparative cross-sectional study involved...